J.P. Morgan Healthcare Conference 2026
Powerful Medical's leadership was in San Francisco for JPM week, taking part in MedTech Innovator's Innovator Partnering, the LifeX and SVB programming on AI-native care, and a full schedule of meetings with strategic partners, investors and industry leaders.
San Francisco, California, USA
January 12–15, 2026
The J.P. Morgan Healthcare Conference is the world's largest and most influential healthcare investment gathering. Now in its 44th year, the invitation-only event draws more than 8,000 participants — senior executives, investors, startups, analysts and policymakers across biotech, pharma, medtech and health tech — to San Francisco's Union Square each January.
Over four days, JPM sets the tone for the year ahead in healthcare: it is where multi-billion-dollar M&A is announced, pipelines and partnerships are unveiled, and capital flows for the sector are shaped. The main conference at the Westin St. Francis is surrounded by a dense ecosystem of partnering events, receptions and one-on-one meetings that spill across the city.
- Venue: The Westin St. Francis, 335 Powell Street, San Francisco, California, USA
- Organiser: J.P. Morgan
- Website: jpmorgan.com
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.